Abstract

Ambu A/S will report quarterly results on August 26, 2026 before-market; consensus points to revenue of 1.65 billion DKK year over year growth of 10.85%, EBIT of 220.09 million DKK year over year growth of 5.01%, and adjusted EPS of DKK 0.61 year over year growth of 3.08%, alongside a review of last quarter’s margin profile and watch items.

Market Forecast

Consensus for the current quarter calls for revenue of 1.65 billion DKK, up 10.85% year over year, EBIT of 220.09 million DKK, up 5.01% year over year, and adjusted EPS of DKK 0.61, up 3.08% year over year. Recent previews do not provide explicit projections for gross profit margin or net margin, so the focus is on top-line acceleration and operating-income stabilization relative to the last reported period.

Medical Technology Solutions remains the primary revenue engine, supported by improving order execution and stable pricing; last quarter it generated 1.57 billion DKK, up 1.22% year over year, and current-quarter consensus implies sequential growth. Within this umbrella, the largest growth potential remains concentrated in the same revenue stream given it constitutes essentially all reported sales, with the aggregate company forecast of 1.65 billion DKK implying the near-term growth vector.

Last Quarter Review

Ambu A/S reported revenue of 1.57 billion DKK up 1.22% year over year with a gross profit margin of 60.27%, net profit attributable to shareholders of 121.00 million DKK, a net margin of 7.69%, and adjusted EPS of DKK 0.46 down 35.21% year over year. Operating profit was 173.00 million DKK down 22.77% year over year, while net profit rose 2.54% sequentially, signaling early stabilization in earnings despite softer operating leverage.

Medical Technology Solutions contributed 1.57 billion DKK in the quarter, effectively the entire revenue base, translating to a 1.22% year over year increase and reflecting steady delivery patterns during the period.

Current Quarter Outlook

Main business

Ambu A/S’s core operations are tracking toward a quarter characterized by top-line acceleration against a relatively modest prior-year comparison, with consensus revenue at 1.65 billion DKK up 10.85% year over year. This shift, relative to last quarter’s 1.22% year over year revenue growth, suggests better conversion of orders into shipments and a more predictable delivery cadence as the quarter progressed. The profile of profitability implied by the data shows EBIT expected at 220.09 million DKK, a 5.01% year over year increase, which points to positive operating leverage but at a lesser pace than revenue growth, implying some reinvestment and/or cost inflation offsetting part of the scale benefits.

The key watch item within core operations is the gross profit margin trajectory relative to last quarter’s 60.27%. Without explicit consensus for this quarter’s gross margin, investors will focus on whether procurement savings, logistics normalization, and mix remain supportive enough to keep gross margin around the prior run-rate. A gross margin print materially above 60% would likely confirm better mix or cost capture; a slip would suggest either a less favorable product mix or transient cost items. With last quarter’s net margin at 7.69% and EPS at DKK 0.46, the consensus EPS of DKK 0.61 indicates expectations for incrementally better below-the-line dynamics versus last quarter, consistent with improved operating momentum.

Cost discipline will be closely scrutinized. The spread between revenue growth of 10.85% year over year and EBIT growth of 5.01% year over year embeds the assumption that operating costs rise as a share of sales versus the revenue growth clip, potentially due to salesforce activity, post-launch support, or normalization of travel and service costs. Monitoring sales and administrative spending intensity, alongside the R&D cadence for product enhancement, will be critical to understanding how quickly the company can translate revenue into sustainable operating profit and EPS.

Largest growth potential

The largest near-term growth potential remains within the same revenue stream that underpins the company’s reported sales. With the main business effectively representing the full revenue mix, the company-level forecast of 1.65 billion DKK serves as a practical proxy for the segment’s near-term performance. The shift from 1.22% year over year revenue growth last quarter to a forecasted 10.85% year over year highlights the expected inflection in volume delivery and order execution within the current quarter.

The degree to which this growth potential translates into earnings expansion depends on the interplay of pricing, volume, and cost structure across manufacturing and commercial support. If volume growth is achieved without heavy discounting and if logistics and procurement efficiencies hold, the business can expand contribution margin. Conversely, if larger account deliveries involve incremental service or onboarding costs within the quarter, EBIT may trail revenue growth as the company seeds future recurring volumes. As a result, the EBIT estimate of 220.09 million DKK, up 5.01% year over year, embeds cautious assumptions on margin capture, implying that investors will likely benchmark the reported EBIT against the consensus to gauge how much of this growth potential is translating into operating leverage.

Working capital dynamics are an additional area to watch as the business scales into forecasted growth. Faster shipment cadence can lift receivables and inventories; the quality of collections and the pace of inventory turns will be essential to underpinning cash conversion from the growth spurt. If the company succeeds in maintaining disciplined receivable cycles and avoids building aging inventory, the cash profile should align with earnings expansion, reinforcing the sustainability of the growth potential implied by the consensus top-line figure.

Key share-price drivers this quarter

Delivery versus the consensus revenue estimate of 1.65 billion DKK is likely to be the central share-price catalyst. A revenue beat of even a small magnitude would validate the anticipated acceleration and could reframe expectations for the subsequent quarter’s run-rate. Conversely, a miss would invite scrutiny on order timing and fulfillment, especially given the favorable comparison to the prior quarter’s 1.22% year over year growth.

Margin directionality will be equally significant. Investors will anchor on the last reported 60.27% gross margin and 7.69% net margin to infer where normalized profitability sits. A report showing gross margin holding near or above 60% while EBIT tracks at or above the 220.09 million DKK estimate would endorse the view that higher volumes are not diluting profitability. If reported figures show operating-expense intensity outpacing the scale benefits, the market could infer that the company is prioritizing growth enablement costs within the quarter, which would likely temper short-term EPS upside but could position the company for steadier output in subsequent periods.

Earnings per share at DKK 0.61 is a third focal point because it condenses multiple moving parts—gross margin, operating spend, and below-the-line items—into one metric investors track quarter to quarter. With last quarter’s EPS at DKK 0.46, the step-up implied by consensus will be read as validation that profitability is on an improving trajectory. However, the multiple will also reflect the quality of the beat or miss: EPS upside driven by temporary items would be discounted compared with upside driven by sustainable margin and operating-income expansion.

Cash conversion and balance-sheet hygiene are likely to influence the stock’s post-print reaction as well. While no specific cash figures are embedded in the consensus provided, investors will be sensitive to commentary on receivables, inventory positioning, and capital allocation across manufacturing, quality, and commercial support. Clarity that operational working capital remains in check while volumes rise will be viewed favorably, as it supports repeatability of the growth trajectory implied by the top-line estimate.

Analyst Opinions

Among the previews available in the review window, sentiment skews mixed, with the common thread being optimism on top-line acceleration tempered by caution on margin capture. Based on the collected viewpoints, the majority stance is constructive on revenue momentum, with the balance of opinions neither explicitly bearish nor calling for a margin retrenchment. In count terms, the identified directional views are predominantly on the cautiously positive side, reflecting the consensus that current-quarter revenue should rise 10.85% year over year to 1.65 billion DKK, with EBIT up 5.01% year over year to 220.09 million DKK and EPS improving 3.08% year over year to DKK 0.61.

The reasoning behind this prevailing view rests on the change in growth cadence versus the prior quarter. Analysts highlight that the last reported period grew only 1.22% year over year on the top line, while the present quarter’s consensus implies a more robust delivery pace and better throughput. That said, the more modest year over year expansion in EBIT relative to revenue is why the majority characterization remains “cautiously constructive” rather than outright bullish: ongoing investment and cost normalization could still limit the flow-through to operating income.

Looking into the print, the majority opinion expects management to emphasize execution on shipment timing and ongoing cost discipline, with the margin narrative revolving around procurement savings and cost normalization rather than aggressive price-led expansion. On EPS, the leap from DKK 0.46 last quarter to the consensus DKK 0.61 is seen as achievable if the company balances reinvestment with operating leverage, while any upside would likely come from better-than-expected gross margin resilience or tighter operating expense control. Overall, the gathered opinions anticipate a quarter that validates revenue acceleration while keeping expectations for margin expansion measured, making revenue, gross margin relative to last quarter’s 60.27%, and EBIT versus the 220.09 million DKK estimate the three most sensitive line items for the share price reaction.